Polar Asset Management Partners’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-500,000
| Closed | – | – | 756 |
|
|
2024
Q4 | $0 | Sell |
500,000
-681,872
| -58% | – | ﹤0.01% | 817 |
|
|
2024
Q3 | $258K | Buy |
1,181,872
+101,872
| +9% | +$22.2K | 0.01% | 463 |
|
|
2024
Q2 | $1.28M | Hold |
1,080,000
| – | – | 0.03% | 347 |
|
|
2024
Q1 | $2M | Hold |
1,080,000
| – | – | 0.03% | 343 |
|
|
2023
Q4 | $2.94M | Buy |
+1,080,000
| New | +$2.94M | 0.05% | 285 |
|
|
2023
Q2 | – | Sell |
-300,000
| Closed | -$3.04M | – | 1054 |
|
|
2023
Q1 | $3.04M | Hold |
300,000
| – | – | 0.05% | 413 |
|
|
2022
Q4 | $3.02M | Hold |
300,000
| – | – | 0.04% | 502 |
|
|
2022
Q3 | $2.93M | Hold |
300,000
| – | – | 0.04% | 594 |
|
|
2022
Q2 | $2.91M | Hold |
300,000
| – | – | 0.03% | 594 |
|
|
2022
Q1 | $2.91M | Hold |
300,000
| – | – | 0.03% | 546 |
|
|
2021
Q4 | $2.91M | Hold |
300,000
| – | – | 0.03% | 504 |
|
|
2021
Q3 | $2.91M | Buy |
+300,000
| New | +$2.91M | 0.03% | 461 |
|